Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,179 | 36,788 | 21,947 | 18,705 | 22,675 |
| Receivables | 18,762 | 23,221 | 19,343 | 17,502 | 15,448 |
| Inventories | 1,856 | 1,565 | 2,477 | 2,201 | 1,404 |
| Other current assets | 2,622 | 1,731 | 898 | 965 | 1,004 |
| TOTAL | $66,880 | $67,043 | $46,064 | $40,794 | $42,975 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 4,942 | 3,508 | 3,197 | 4,082 | 3,428 |
| TOTAL | $4,942 | $3,508 | $3,197 | $4,082 | $3,428 |
| Total Assets | $71,822 | $70,551 | $49,261 | $44,876 | $46,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 248 | N/A |
| Accounts payable and accrued liabilities | 6,281 | 4,635 | 5,866 | 5,941 | 5,280 |
| Accrued Expenses | 3,057 | 5,635 | 3,701 | 2,225 | 2,843 |
| Other current liabilities | 248 | 248 | 248 | N/A | 248 |
| TOTAL | $9,586 | $10,518 | $9,815 | $8,414 | $8,371 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 18,106 | 18,093 | 18,080 |
| Other Non-Current Liabilities | 24,561 | 24,561 | 25,832 | 25,832 | 25,832 |
| TOTAL | $24,561 | $24,561 | $43,938 | $43,925 | $43,912 |
| Total Liabilities | $34,147 | $35,079 | $53,753 | $52,339 | $52,283 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,737 | 34,475 | 28,117 | 27,832 | 27,619 |
| Common Shares | 191,229 | 189,906 | 147,652 | 146,165 | 145,979 |
| Retained earnings | -229,221 | -229,422 | -224,636 | -223,998 | -220,846 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $37,675 | $35,472 | $-4,492 | $-7,463 | $-5,880 |
| Total Liabilities And Equity | $71,822 | $70,551 | $49,261 | $44,876 | $46,403 |